Corbus Pharmaceuticals Holdings (CRBP) Return on Sales (2015 - 2022)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Return on Sales of 9.81% for Q2 2022, down 586.0% year-over-year from 2.02% in Q2 2021, and down 81.7% quarter-over-quarter from 5.4% in Q1 2022.
Corbus Pharmaceuticals Holdings (CRBP) Return on Sales (2015 - 2022) Analysis & Trends
Corbus Pharmaceuticals Holdings' Return on Sales history runs 8 years deep, the most recent figure standing at 9.81% for Q2 2022.
- In Q2 2022, Return on Sales fell 586.0% year-over-year to 9.81%; the TTM figure through Jun 2022 stood at 9.81% (down 929.0% YoY), while the FY2021 annual figure was 1.49%, down 110.0% from the prior year.
- Return on Sales for Q2 2022 stood at 9.81%, down from 5.4% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q4 2019, with the low at 9.81% in Q2 2022.
- The 5-year median for Return on Sales is 0.4% (2018), against an average of 1.79%.
- The sharpest annual moves came in 2018 and 2022: Return on Sales jumped 57 bps in 2018, then slumped 586 bps in 2022.
- Corbus Pharmaceuticals Holdings' Return on Sales stood at 0.09% in 2018, then jumped by 110 bps to 0.01% in 2019, then sank by 1411 bps to 0.12% in 2020, then sank by 1434 bps to 1.91% in 2021, then slumped by 412 bps to 9.81% in 2022.
- Business Quant data shows CRBP's Return on Sales at 9.81% in Q2 2022, 5.4% in Q1 2022, and 1.91% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -9.81% |
| Mar 31, 2022 | -5.40% |
| Dec 31, 2021 | -1.91% |
| Sep 30, 2021 | -5.41% |
| Jun 30, 2021 | -3.95% |
| Mar 31, 2021 | -0.80% |
| Dec 31, 2020 | -0.12% |
| Sep 30, 2020 | -0.55% |
| Jun 30, 2020 | -2.42% |
| Mar 31, 2020 | -0.33% |
| Dec 31, 2019 | 0.01% |
| Sep 30, 2019 | -0.18% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.23% |
| Dec 31, 2018 | -0.09% |
| Sep 30, 2018 | -0.43% |
| Jun 30, 2018 | -0.36% |
| Mar 31, 2018 | -0.12% |
| Dec 31, 2017 | -0.36% |
| Sep 30, 2017 | -0.46% |